| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.029 | 0.5 |